HomeInsightsStock Comparison

Glenmark Pharmaceuticals Ltd vs Gufic Biosciences Ltd Stock Comparison

Glenmark Pharmaceuticals Ltd vs Gufic Biosciences Ltd Stock Comparison

Last Updated on: Aug 23, 2025

Key Highlights

  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1936 as of 22 Aug 15:30.
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 44.2 on March 2023 . This represents a CAGR of 55.81% over 4 yearsThe P/E Ratio of Gufic BioSciences Ltd changed from 33 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 27019 crore on March 2024 to ₹ 13120 crore on March 2023 . This represents a CAGR of -13.45% over 5 yearsThe Market Cap of Gufic BioSciences Ltd changed from ₹ 2839 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Glenmark Pharmaceuticals Ltd for the Jun '25 is ₹ 3290 crore as compare to the Mar '25 revenue of ₹ 3267 crore. This represent the growth of 0.7% The revenue of Gufic BioSciences Ltd for the Jun '25 is ₹ 224.65 crore as compare to the Mar '25 revenue of ₹ 205.41 crore. This represent the growth of 9.37%.
  • The ebitda of Glenmark Pharmaceuticals Ltd for the Jun '25 is ₹ 283.73 crore as compare to the Mar '25 ebitda of ₹ 199.89 crore. This represent the growth of 41.94% The ebitda of Gufic BioSciences Ltd for the Jun '25 is ₹ 34.23 crore as compare to the Mar '25 ebitda of ₹ 26.77 crore. This represent the growth of 27.87%.
  • The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 46.97 crore over 9 quarters. This represents a CAGR of -44.00% The net profit of Gufic BioSciences Ltd changed from ₹ 20.62 crore to ₹ 13.07 crore over 9 quarters. This represents a CAGR of -18.34% .
  • The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 1.37 % on March 2024 . This represents a CAGR of -23.44% over 5 yearsThe Dividend Payout of Gufic BioSciences Ltd changed from 2.14 % on March 2020 to 1.16 % on March 2024 . This represents a CAGR of -11.53% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
  • The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.

About Gufic BioSciences Ltd

  • Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
  • Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
  • The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
  • The Company was incorporated in July, 1984.
  • The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals to conduct AGM

Glenmark Pharmaceuticals announced that the Annual General Meeting(AGM) of the company wil...

Read more

23 Aug 2025 11:07

News

Glenmark USA to launch Micafungin for Injection 50 mg/vial and 100 mg/vial

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of Micafungin ...

Read more

19 Aug 2025 10:07

News

Glenmark Pharma's US arm to launch Micafungin injection in the US market

The product is bioequivalent and therapeutically equivalent to the reference listed drug M...

Read more

19 Aug 2025 12:11

News

Glenmark Pharmaceuticals announces board meeting date

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

Read more

05 Aug 2025 18:06

News

Glenmark Pharmaceuticals Ltd spurts 1.22%, up for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting...

Read more

28 Jul 2025 13:05

News

Glenmark Pharmaceuticals receives revision in outlook on LT bank facilities

India Ratings and Research (Ind-Ra) has revised the Outlook on Glenmark Pharmaceuticals' (...

Read more

23 Jul 2025 18:35

Gufic BioSciences Ltd News Hub

News

Gufic BioSciences to convene board meeting

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

08 Aug 2025 16:59

News

Gufic BioSciences appoints senior management personnel

Gufic BioSciences has appointed Rajesh Kaul as Senior President ' Sparsh Cluster, Senior M...

Read more

02 Jul 2025 18:34

News

Board of Gufic BioSciences recommends final dividend

Gufic BioSciences announced that the Board of Directors of the Company at its meeting held...

Read more

30 May 2025 20:18

News

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

24 May 2025 18:18

News

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

08 Feb 2025 14:21

News

Gufic Biosciences tumbles after Q2 PAT drops 6% YoY to Rs 22 cr

Profit before tax (PBT) fell 5.46% YoY to Rs 29.25 crore during the quarter. Total expense...

Read more

18 Nov 2024 11:09

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Gufic BioSciences Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gufic BioSciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Gufic BioSciences Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Gufic BioSciences Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 54,649 Cr while Market cap of Gufic BioSciences Ltd is 3,639 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Gufic BioSciences Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Gufic BioSciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Gufic BioSciences Ltd?

As of August 23, 2025, the Glenmark Pharmaceuticals Ltd stock price is INR ₹1936.55. On the other hand, Gufic BioSciences Ltd stock price is INR ₹362.95.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Gufic BioSciences Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Gufic BioSciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions